The PhD candidate will assist in the development of a direct from sample diagnostic system that differentiates "killers" and "colonisers". The work will centre on the diagnosis of bacterial infections, where distinction between pathogens and colonising, contaminating bacterial flora is key. In this work consecutive and optimised versions of the instrument and the biochemical assays will be tested in real life clinical settings. From a more fundamental perspective, diagnosis of other infectious syndromes will be included. In addition, expertise on adhesin biology as available in the Stradivarious network will be used to optimise and refine our diagnostic tests. The study of bacterial enrichment through adhesin and ligand affinity assays will be piloted.
The work is in close collaboration with other both academic and industrial clinical microbiology and infectious diseases R&D groups in and outside the Stradivarious network. The position offers the opportunity of internships with both academic and industrial partners.
Methods will include the experimental clinical validation and verification of new generations of the KAIROS diagnostic platform. Clinical studies will be performed in various healthcare settings, allowing new applications of the platform to be developed.
We are recruiting 15 fully-funded doctoral candidates for 36-month positions across our European network, with guaranteed secondments in both academic and industrial partner institutions.
We are recruiting 15 fully-funded doctoral candidates for 36-month positions across our European network, with guaranteed secondments in both academic and industrial partner institutions.
.png)